We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Fevertree Drinks Plc | LSE:FEVR | London | Ordinary Share | GB00BRJ9BJ26 | ORD 0.25P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 4.00 | 0.37% | 1,079.00 | 217,622 | 16:29:47 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 1,078.00 | 1,081.00 | 1,096.00 | 1,070.00 | 1,090.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Wine & Alcoholic Bev-whsl | 364.4M | 15.4M | 0.1320 | 81.74 | 1.26B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 18:14:50 | O | 1,029 | 1,079.715 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 27/3/2024 | 07:00 | UK RNS | Fevertree Drinks PLC Holding(s) in Company |
| 26/3/2024 | 13:05 | ALNC |  TAKING AIM: Fevertree's margin ambition bodes well for profit recovery |
| 26/3/2024 | 10:15 | ALNC | Fevertree profit slips but sales fizz stateside as US overtakes the UK |
| 26/3/2024 | 07:00 | UK RNS | Fevertree Drinks PLC FY23 Preliminary Results to 31 December 2023 |
| 26/1/2024 | 07:50 | ALNC | IN BRIEF: Fevertree Drinks Chair Domenic De Lorenzo buys 45,000 shares |
| 25/1/2024 | 12:05 | UK RNS | Fevertree Drinks PLC Director/PDMR Shareholding |
| 25/1/2024 | 10:23 | ALNC | Fevertree sales rise and profit in line despite "challenging" 2023 |
| 25/1/2024 | 07:00 | UK RNS | Fevertree Drinks PLC FY23 pre-close trading update |
| 18/1/2024 | 14:30 | UKREG | Fevertree Drinks PLC Block Admission Application |
| 18/1/2024 | 14:30 | UKREG | Fevertree Drinks PLC Admission Application |
Fevertree Drinks (FEVR) Share Charts1 Year Fevertree Drinks Chart |
|
1 Month Fevertree Drinks Chart |
Intraday Fevertree Drinks Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 10/4/2024 | 09:27 | FEVER TREE with chart | 8,642 |
| 27/4/2023 | 06:22 | Fevertree Drinks PLC (Fever-Tree) | 1,966 |
| 24/11/2022 | 12:15 | Fevertree | 156 |
| 26/11/2021 | 11:18 | Fevertree - private investor | 971 |
| 26/3/2019 | 10:54 | Fevertree Drinks FY Results 26.03.19 Preview | 5 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 17:14:58 | 1,079.72 | 1,029 | 11,110.27 | O |
| 17:11:54 | 1,076.19 | 821 | 8,835.49 | O |
| 17:10:41 | 1,077.80 | 346 | 3,729.17 | O |
| 16:56:54 | 1,078.00 | 492 | 5,303.76 | O |
| 16:56:37 | 1,079.00 | 2,969 | 32,035.51 | O |
| Top Posts |
|---|
Posted at 18/4/2024 09:20 by Fevertree Drinks Daily Update Fevertree Drinks Plc is listed in the Wine & Alcoholic Bev-whsl sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree Drinks was 1,075p.Fevertree Drinks currently has 116,677,711 shares in issue. The market capitalisation of Fevertree Drinks is £1,258,952,502. Fevertree Drinks has a price to earnings ratio (PE ratio) of 81.74. This morning FEVR shares opened at 1,090p |
Posted at 26/3/2024 10:27 by disc0dave46 Hi CTUS up 22%, that's the future.At first glance a bit underwhelming tbh with them missing their revised Rev target for the year of £380m-£390m. But margin as revised at H1 so in the price. Pbt also down 28% so again at first glance doesn't look good.But if they double their EBITDA and they've said 15% margin so if my quick calcs are correct FY24 Rev is looking like c £407m (consensus £395m) that's +12% and ergo pbt will be double at IMO c £45m, eps c 30p to 32p.As posted previously it's not about the short/medium term it's getting those margins back to 2017-18 levels. |
Posted at 31/1/2024 08:23 by castleford tiger AIM so IHT funds in this. I guess.I hear what has been said but remember I sell the stuff. It’s very price sensitive and sells on promo but much slower at full retail. At 30 p for a can of Schp we have noticed people moving back against the 85/90p per bottle. The gin market is very mature now. Prices went up 10% last year and U.K. sales did not increase LFL. Tiger |
Posted at 27/1/2024 21:08 by apad In these times of highly fluctuating costs, how many years of revenue buys the company is a good metric.FEVR is about 3.5 years. Given the potential for growth this is not so expensive. Amusingly Bioventix is 19 years 😊 apad |
Posted at 27/1/2024 10:47 by disc0dave46 Some very large buys over the past few months.Held these years ago and did very well (lucky), never understood the high rating either but went with PEG, which I notice is below 1 again. Forecast eps for FY24 is on a par with 2017 during their significant growth phase, share price then went from £11 to £21......whilst UK growth isn't anywhere near going to be the same as then, the US looks very much like it could be!.Sometimes perceived value on PE alone misses the potential IMO. With revenues at all time highs and still growing despite the macros, getting back to profitability margins pre pandemic and the skys the limit!, just check out their op margins and ROCE pre 2020. |
Posted at 17/1/2024 10:38 by philanderer JPMorgan cuts Fevertree Drinks price target to 1,090 (1,150) pence - 'neutral' |
Posted at 16/1/2024 14:14 by philanderer Liberum upgrades Fevertree on recovery prospectsLiberum has upgraded premium mixer maker Fevertree (FEVR) as a trough in margins indicates a recovery in this year and next. Analyst Anubhav Malhotra upgraded his recommendation from ‘hold’ to ‘buy’ and increased the target price from £12.00 to £13.00 on the stock, which was trading at £9.98 on Monday. Malhotra said the company’s strategy ‘has been focused on market share gains against a backdrop of significant input cost inflation over the last two years’. Margins have ‘troughed̵ ‘We see scope for a greater recovery in 2024 and 2025 than consensus expects and therefore move to ‘buy’ ‘Despite the [fact] that ‘bad news’ might not be over, the valuation at 17x 12 months forward consensus embedded value/Ebitda and 28x price/earnings – 40-50% below historic average – looks reasonable.’ Mahotra said that for investors ‘wanting to build a position, now is the time considering the low average daily volume of 265,000’. citywire.com |
Posted at 16/1/2024 10:37 by gipps Hi Mike yes i am in Fevertree and Distil and hope that this year they both recover to where they were some ago,i really think that they are both on the recovery path.Distil has a couple of big names in this field invested in it and hope that their in put will seriously improve the share price in time. |
Posted at 12/9/2023 09:42 by edwardt 24 ebitda margins has been revised up from consensus expectations to 15% - as i say, that is where the market should be looking. anyway,agree the results were not exactly great but the muted share price reaction is right imo. |
Posted at 12/9/2023 07:40 by johndoe23 For some reason this stock defies logic regarding share price movements. But yes, should be marked down |
Posted at 04/4/2023 12:53 by apad Nice one, aiming.I was in an hotel in Buxton. FEVR the only tonic on offer. Five quid for a double Tanqueray and FEVR tonic. In Jersey (UK) folks are still going to the pubs and paying ten quid for a large glass of wine! There seems to be plenty of alternative 'posh' tonics in the UK supermarkets but they don't seem to have the cachet of FEVR. I guess FEVR management has the pricing skills to keep their stock moving. Even if glass bottles are expensive! I think I'll match my FEVR holding with some CPC shares. It seems that the alcohol culture is not a 'consumer discretionary'. 😊 Keep the insider information coming Castleford Tiger. Much appreciated. apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
